“
“Sixty-seven percent of French pilgrims reported to have traveled out of France just before the 2010 Hajj (mainly in North Africa) and 26% planned to do so after leaving Saudi Arabia. Surveillance selleck inhibitor of Hajj-associated infectious diseases in returned French pilgrims should be coordinated between France and North African countries. More than 2.78 million pilgrims traveled to Mecca to perform the Hajj in 2010, of which 65% were from outside the Kingdom of Saudi Arabia (http://www.cdsi.gov.sa/english/index.php?option=com_doc man&Itemid=173). In 2008, international pilgrims from the World Health Organization’s

European region ranked third after pilgrims from the Eastern Mediterranean Region and the South-East Asia Region.1 Of pilgrims leaving Saudi Arabia in 2008 for Western Europe, the highest volume of passengers traveled to London, Paris, Manchester, buy LDK378 and Frankfurt.1 In 2010, a total of 23,000 visas were delivered to French pilgrims by the Embassy of Saudi Arabia in Paris (http://www. pelerindumonde.org/article-4914223.html). Each year, approximately 2,000

Muslims travel from Marseille, south France, to participate in the Hajj. Health risks during the Hajj are a critical issue due to the extreme congestion of people with communicable diseases, the leading cause of morbidity. The risk of spread, particularly for respiratory infections, applies both at the time of the event and after it, during the specific infection’s incubation period when participants travel or return to their homes.2 Attack rates of 60% of respiratory symptoms have been observed in French pilgrims from Marseille.3 Enhanced public health surveillance for communicable diseases during mass gatherings (MG) is one of the procedures that the World Health Organization recommends to reduce the time to detection of illness so that public health interventions (eg, post-exposure prophylaxis) can be employed to prevent further illness, or to reduce morbidity and mortality. Prolonged surveillance after the MG is also critical in order to ensure the detection of diseases triclocarban with longer incubation periods that may be related to the event.4 We previously noted that

the majority of French pilgrims from Marseille emigrated from North Africa and frequently traveled back to their country of origin, to visit friends and relatives.5 The objective of this study was to prospectively describe international travel patterns in French Hajj pilgrims before and after the Hajj of 2010. A total of 632 pilgrims attending two Travel Medicine Centers, in Marseille, France to get required vaccination against meningitis prior to the 2010 Hajj, were prospectively surveyed between September 19, 2010 and October 29, 2010. Only Hajj and not Umra pilgrims were included in the survey. Attendees older than 18 years were proposed to participate in the survey and recruited on a voluntary basis and participants were asked to sign a written consent form.